NVOS logo

Novo Integrated Sciences (NVOS)

Profile

Full Name

Novo Integrated Sciences, Inc.

Ticker Symbol

NVOS

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Care Facilities

Country

United States

IPO

February 23, 2021

Indexes

Not included

Website

http://www.novointegrated.com

Employees

115

Key Details

Price

$0.00(0.00%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$12.57M(+7.11% YoY)

Annual EPS

-$1.30(+88.48% YoY)

PE ratio

-

Next earnings date

Apr 15, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.00
NVOS price is $0.00

30-Day Relative Volume

0.01
NVOS 30-day relative volume is 0.01

Price Performance

Price Most recent change

0%
NVOS {parameterFullLabel} has remained unchanged on Apr 14, 2025

Price YTD change

-98.08%
NVOS price is down -98.08% since January 1st

Price 1-year change

-99.78%
NVOS price is down -99.78% year-on-year

Price 3-year change

-100%
NVOS price is down -100% over the past 3 years

Price Range

Price All-time high

$149.80
NVOS price is currently -100.00% below its historical high of $149.80

Price 3-year low

$0.00
NVOS price is currently at its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$19.73K
NVOS market capitalization is $19.73 thousand

Market cap 3-year change

-99.97%
NVOS market capitalization is down -99.97% over the past 3 years

Market cap All-time high

$152.20M
NVOS market capitalization is currently -99.99% below its historical high of $152.20 million

Market cap sector rank

1.81%
NVOS market capitalization is higher than 1.81% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+17.36%
NVOS shares outstanding is up +17.36% year-on-year

Shares Outstanding 3-Year Change

+559.59%
NVOS shares outstanding is up +559.59% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.27
NVOS beta is 0.27

200-day SMA

$0.21
NVOS price is currently -99.53% below its 200-day simple moving average

50-day SMA

$0.04
NVOS price is currently -97.51% below its 50-day simple moving average

RSI

27.59
NVOS 14-day relative strength index is 27.59

Volume

0.01
NVOS 30-day relative volume is 0.01

ATR

$0.00
NVOS average true range is $0.00

10-day Historical Volatility

467.51%
NVOS 10-day historical volatility is 467.51%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$12.57M
NVOS annual revenue is $12.57 million

Revenue Analysts estimate

-
NVOS annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

+7.11%
NVOS annual revenue is up +7.11% year-on-year

Revenue Sector rank

31.02%
NVOS annual revenue is higher than 31.02% of companies in Healthcare sector

EPS

EPS

-$1.30
NVOS annual earnings per share is -$1.30

EPS Analysts estimate

-
NVOS annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

+88.48%
NVOS annual earnings per share is up +88.48% year-on-year

EPS Sector rank

49.79%
NVOS annual earnings per share is higher than 49.79% of companies in Healthcare sector

Profit

Gross profit

$4.95M
NVOS annual gross profit is $4.95 million

Gross margin

39.39%
NVOS annual gross profit margin is 39.39%

Operating profit

-$8.55M
NVOS annual operating income is -$8.55 million

Operating margin

-68.03%
NVOS annual operating profit margin is -68.03%

Net income

-$13.21M
NVOS annual net profit is -$13.21 million

Net margin

-105.11%
NVOS annual net profit margin is -105.11%

Expenses

Total expenses

$21.13M
NVOS annual total expenses is $21.13 million

Operating expenses

$13.51M
NVOS annual total operating expenses is $13.51 million

Cost of goods sold

$7.62M
NVOS annual cost of goods sold is $7.62 million

Selling, general & administrative expenses

$13.51M
NVOS annual SGA is $13.51 million

Depreciation and amortization

$2.30M
NVOS annual depreciation & amortization is $2.30 million

Interest expense

$5.12M
NVOS annual interest expense is $5.12 million

Income tax

$0.00
NVOS annual income tax is $0.00

EBIT & EBITDA

EBIT

-$8.15M
NVOS annual earnings before interest & taxes is -$8.15 million

EBITDA

-$5.85M
NVOS annual EBITDA is -$5.85 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$35.56M
NVOS annual total assets is $35.56 million

Non current assets

$31.18M
NVOS annual long term assets is $31.18 million

Current assets

$4.39M
NVOS annual total current assets is $4.39 million

Cash and cash equivalents

$416.30K
NVOS annual cash & cash equivalents is $416.30 thousand

Accounts receivable

$2.22M
NVOS annual accounts receivable is $2.22 million

Inventory

$1.11M
NVOS annual inventory is $1.11 million

Liabilities

Total liabilities

$11.06M
NVOS annual total liabilities is $11.06 million

Long term liabilities

$3.16M
NVOS annual total long term liabilities is $3.16 million

Current liabilities

$7.90M
NVOS annual total current liabilities is $7.90 million

Accounts payable

$3.51M
NVOS annual accounts payable is $3.51 million

Debt

Total debt

$4.47M
NVOS annual total debt is $4.47 million

Total debt 1-year change

-65.59%
NVOS annual total debt is down -65.59% year-on-year

Long term debt

$1.76M
NVOS annual long term debt is $1.76 million

Short term debt

$2.71M
NVOS annual short term debt is $2.71 million

Equity & Capital

Shareholders equity

$24.82M
NVOS annual stockholders equity is $24.82 million

Book value

$24.82M
NVOS annual book value is $24.82 million

Retained earnings

-$67.03M
NVOS annual retained earnings is -$67.03 million

Working capital

-$3.52M
NVOS annual working capital is -$3.52 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$2.24M
NVOS annual cash flow from operations is -$2.24 million

Cash from operations 1-year change

+61.88%
NVOS annual cash flow from operations is up +61.88% year-on-year

Cash from investing

-$49.20K
NVOS annual cash flow from investing activities is -$49.20 thousand

Cash from investing 1-year change

-130.09%
NVOS annual cash flow from investing activities is down -130.09% year-on-year

Cash from financing

$763.90K
NVOS annual cash flow from financing activities is $763.90 thousand

Cash from financing 1-year change

+278.86%
NVOS annual cash flow from financing activities is up +278.86% year-on-year

CAPEX

CAPEX

$49.20K
NVOS annual capital expenditures is $49.20 thousand

CAPEX 1-year change

-74.13%
NVOS annual capital expenditures is down -74.13% year-on-year

Free Cash Flow

Free cash flow

-$2.29M
NVOS annual free cash flow is -$2.29 million

Free cash flow 1-year change

+62.26%
NVOS annual free cash flow is up +62.26% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

39.39%
NVOS annual gross profit margin is 39.39%

Operating margin

-68.03%
NVOS annual operating profit margin is -68.03%

Net margin

-105.11%
NVOS annual net profit margin is -105.11%

ROA & ROE

ROA

-34.58%
NVOS annual return on assets is -34.58%

ROE

-56.78%
NVOS annual return on equity is -56.78%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
NVOS price to earnings ratio value is unknown

PE ratio Sector rank

-
NVOS price to earnings ratio is unknown

PB Ratio

PB ratio

0.00
NVOS price to book ratio is 0.00

PB ratio Sector rank

16.71%
NVOS price to book ratio is higher than 16.71% of companies in Healthcare sector

PS Ratio

PS ratio

0.00
NVOS price to sales ratio is 0.00

PS ratio Sector rank

1.54%
NVOS price to sales ratio is higher than 1.54% of companies in Healthcare sector

Enterprise value

Enterprise value

$2.98M
NVOS enterprise value is $2.98 million

Enterprise value Sector rank

16.53%
NVOS enterprise value is higher than 16.53% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.19
NVOS EV/EBITDA is -0.19

EV/EBITDA Sector rank

58.61%
NVOS EV/EBITDA is higher than 58.61% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

0.56
NVOS annual current ratio is 0.56

Quick ratio

0.42
NVOS annual quick ratio is 0.42

Leverage

Debt to equity

0.09
NVOS annual debt to equity ratio is 0.09

Interest coverage ratio

-1.59
NVOS annual interest coverage ratio is -1.59

Risk & Stability

Piotroski F-Score

3
NVOS piotroski f-score is 3

Altman Z-Score

-3.16
NVOS altman z-score is -3.16

Analyst ratings

Recent major analysts updates

No data about analysts updates

Institutional Ownership

Similar stocks

VAXX logo
Vaxxinity (VAXX)
SCPS logo
Scopus BioPharma (SCPS)
PXMD logo
PaxMedica (PXMD)
Holdco Nuvo Group DG (NUVO)
EVLO logo
Evelo Biosciences (EVLO)
CMRA logo
Comera Life Sciences Holdings (CMRA)
NMRD logo
Nemaura Medical (NMRD)
STAB logo
Statera Biopharma (STAB)
CALA logo
Calithera Biosciences (CALA)
  • What is the ticker symbol for Novo Integrated Sciences?
  • Does Novo Integrated Sciences pay dividends?
  • What sector is Novo Integrated Sciences in?
  • What industry is Novo Integrated Sciences in?
  • What country is Novo Integrated Sciences based in?
  • When did Novo Integrated Sciences go public?
  • Is Novo Integrated Sciences in the S&P 500?
  • Is Novo Integrated Sciences in the NASDAQ 100?
  • Is Novo Integrated Sciences in the Dow Jones?
  • When was Novo Integrated Sciences's last earnings report?
  • When does Novo Integrated Sciences report earnings?

What is the ticker symbol for Novo Integrated Sciences?

The ticker symbol for Novo Integrated Sciences is NASDAQ:NVOS

Does Novo Integrated Sciences pay dividends?

No, Novo Integrated Sciences does not pay dividends

What sector is Novo Integrated Sciences in?

Novo Integrated Sciences is in the Healthcare sector

What industry is Novo Integrated Sciences in?

Novo Integrated Sciences is in the Medical Care Facilities industry

What country is Novo Integrated Sciences based in?

Novo Integrated Sciences is headquartered in United States

When did Novo Integrated Sciences go public?

Novo Integrated Sciences's initial public offering (IPO) was on February 23, 2021

Is Novo Integrated Sciences in the S&P 500?

No, Novo Integrated Sciences is not included in the S&P 500 index

Is Novo Integrated Sciences in the NASDAQ 100?

No, Novo Integrated Sciences is not included in the NASDAQ 100 index

Is Novo Integrated Sciences in the Dow Jones?

No, Novo Integrated Sciences is not included in the Dow Jones index

When was Novo Integrated Sciences's last earnings report?

Novo Integrated Sciences's most recent earnings report was on Dec 18, 2024

When does Novo Integrated Sciences report earnings?

The next expected earnings date for Novo Integrated Sciences is Apr 15, 2025
On this page